Current Size: 100%
Survival statistics
Note: Survival is presented by area of residence at the time of diagnosis.
Cancer | Years | Method | Sex | Age | Region | Survived | Net survival | 95% lower | 95% upper |
---|---|---|---|---|---|---|---|---|---|
All ex C44 | 2010-2014 | hybrid | Both | 15-99 | all | 1.00 years | 77.4% | 77.1% | 77.7% |
All ex C44 | 2010-2014 | hybrid | Both | 15-99 | all | 5.00 years | 62.4% | 62.0% | 62.8% |
All ex C44 | 2010-2014 | hybrid | Both | 15-99 | all | 10.00 years | 58.5% | 57.9% | 59.2% |
All ex C44 | 2010-2014 | hybrid | Both | 15-99 | HSE Dublin/Mid-Leinster | 1.00 years | 78.6% | 78.0% | 79.1% |
All ex C44 | 2010-2014 | hybrid | Both | 15-99 | HSE Dublin/Mid-Leinster | 5.00 years | 63.6% | 62.8% | 64.3% |
All ex C44 | 2010-2014 | hybrid | Both | 15-99 | HSE Dublin/Mid-Leinster | 10.00 years | 60.0% | 58.8% | 61.3% |
All ex C44 | 2010-2014 | hybrid | Both | 15-99 | HSE Dublin/North-East | 1.00 years | 76.8% | 76.2% | 77.5% |
All ex C44 | 2010-2014 | hybrid | Both | 15-99 | HSE Dublin/North-East | 5.00 years | 61.7% | 60.8% | 62.6% |
All ex C44 | 2010-2014 | hybrid | Both | 15-99 | HSE Dublin/North-East | 10.00 years | 58.2% | 56.9% | 59.6% |
All ex C44 | 2010-2014 | hybrid | Both | 15-99 | HSE South | 1.00 years | 76.8% | 76.3% | 77.4% |
All ex C44 | 2010-2014 | hybrid | Both | 15-99 | HSE South | 5.00 years | 61.4% | 60.7% | 62.2% |
All ex C44 | 2010-2014 | hybrid | Both | 15-99 | HSE South | 10.00 years | 56.8% | 55.6% | 58.2% |
All ex C44 | 2010-2014 | hybrid | Both | 15-99 | HSE West | 1.00 years | 77.2% | 76.6% | 77.8% |
All ex C44 | 2010-2014 | hybrid | Both | 15-99 | HSE West | 5.00 years | 62.7% | 61.9% | 63.5% |
All ex C44 | 2010-2014 | hybrid | Both | 15-99 | HSE West | 10.00 years | 58.9% | 57.7% | 60.2% |